Literature DB >> 24580026

HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil.

T D Veit1, C P S de Lima, L C Cavalheiro, S M Callegari-Jacques, C V Brenol, J C T Brenol, R M Xavier, M F L da Cunha Sauma, E J M dos Santos, J A B Chies.   

Abstract

In this study, we sought to investigate the genetic influence of two HLA-G 3'-untranslated region (3'-UTR) polymorphisms - 14 bp (rs66554220) and +3142C>G (rs1063320) and their compounding haplotypes in susceptibility to rheumatoid arthritis (RA) in a two-region Brazilian study comprising of 539 patients and 489 controls. All subjects were polymerase chain reaction (PCR) genotyped for the referred polymorphisms and logistic regression models controlling for sex, city and age were performed. Homozygozity for the +3142G allele was associated with an increased risk of RA [odds ratio (OR) = 1.45, 95% confidence interval (CI) = 1.075-1.959, P(Bonf)  = 0.030], whereas no association was observed for the 14 bp polymorphism. Haplotype comparisons between patients and controls showed a decreased frequency of the delC haplotype in patients (OR = 0.70, 95% CI = 0.521-0.946, P(Bonf)  = 0.040), which remained significant in the rheumatoid factor (RF)-positive group (OR = 0.66, 95% CI = 0.482-0.900, P(Bonf)  = 0.018), but not in the RF-negative group. These results corroborate the hypothesis of an involvement of HLA-G in the susceptibility of RA. The +3142G allele is associated with haplotype lineages that share high identity and are regarded as low producers. The presence of the G allele in homozygosis could be responsible for a low HLA-G expression profile that could favor the triggering of RA.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  14 bp; 3′-untranslated region; Brazil; disease susceptibility; haplotype; human leukocyte antigen-G; polymorphism; rheumatoid arthritis

Mesh:

Substances:

Year:  2014        PMID: 24580026     DOI: 10.1111/tan.12311

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.

Authors:  Inès Zidi; Olfa Dziri; Nour Zidi; Refaat Sebai; Nadia Boujelebene; Amna Ben Hassine; Hamza Ben Yahia; Ahmed Baligh Laaribi; Wafa Babay; Hela Rifi; Amel Mezlini; Hanene Chelbi
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

Review 2.  Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-10-18       Impact factor: 2.631

3.  Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity.

Authors:  Erick C Castelli; Jaqueline Ramalho; Iane O P Porto; Thálitta H A Lima; Leandro P Felício; Audrey Sabbagh; Eduardo A Donadi; Celso T Mendes-Junior
Journal:  Front Immunol       Date:  2014-10-06       Impact factor: 7.561

4.  "HLA-G 3'UTR gene polymorphisms and rheumatic heart disease: a familial study among South Indian population".

Authors:  Maheshkumar Poomarimuthu; Sivakumar Elango; Sambath Soundrapandian; Jayalakshmi Mariakuttikan
Journal:  Pediatr Rheumatol Online J       Date:  2017-02-01       Impact factor: 3.054

5.  Evaluation of HLA-G 14 bp Ins/Del and +3142G>C Polymorphism with Susceptibility and Early Disease Activity in Rheumatoid Arthritis.

Authors:  Mohammad Hashemi; Mahnaz Sandoughi; Seyed Amirhossein Fazeli; Gholamreza Bahari; Maryam Rezaei; Zahra Zakeri
Journal:  Adv Med       Date:  2016-08-16

Review 6.  Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.

Authors:  Fabio Morandi; Roberta Rizzo; Enrico Fainardi; Nathalie Rouas-Freiss; Vito Pistoia
Journal:  J Immunol Res       Date:  2016-08-29       Impact factor: 4.818

7.  Rapid high-resolution melting method to identify human leukocyte antigen-G (HLA-G) 3' untranslated region polymorphism +3142C/G (rs1063320).

Authors:  Hamza Ben Salah; Refka Jelassi; Ines Zidi; Amor Ben Amor; Sondes Bizid; Radhia Ammi; Lamia Guizani; Aida Bouratbine; Karim Aoun; Hanen Chelbi
Journal:  Mol Genet Genomic Med       Date:  2021-10-03       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.